US 11357777
Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)
granted A61KA61K31/197A61K31/198
Quick answer
US patent 11357777 (Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)) held by Cyclerion Therapeutics, Inc. expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cyclerion Therapeutics, Inc.
- Grant date
- Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/197, A61K31/198, A61K31/4985, A61K31/506